Cash & equivalents decreased 57.6%
Cash & equivalents changed -57.6% from the comparable as-filed period. The change ranks at the 73th percentile of 215 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -57.6% from the comparable as-filed period. The change ranks at the 73th percentile of 215 prior comparable changes.
Inventory changed +32.3% from the comparable as-filed period. The change ranks at the 55th percentile of 51 prior comparable changes.
Net income changed +95.9% from the comparable as-filed period. The change ranks at the 94th percentile of 108 prior comparable changes.
Operating income changed +99.5% from the comparable as-filed period. The change ranks at the 94th percentile of 126 prior comparable changes.
Operating margin changed +29091 basis points from the comparable as-filed period. The change ranks at the 88th percentile of 58 prior comparable changes.
Revenue changed +296.1% from the comparable as-filed period. The change ranks at the 95th percentile of 61 prior comparable changes.
Selling, general & administrative changed +59.9% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Research & development changed +18.5% from the comparable as-filed period. The change ranks at the 29th percentile of 126 prior comparable changes.
Debt changed +0.0% from the comparable as-filed period. The change ranks at the 33th percentile of 57 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.